Return to homepagePandemic Pact

COVID-19 RELATED STUDY INVOLVING DOGS

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N91019D00013-0-759102000002-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $597,893

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    DAVID MCCORMICK

  • Research Location

    United States of America

  • Lead Research Institution

    IIT RESEARCH INSTITUTE

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Human recombinant ACE2 will be administered to dogs as an aerosol to assess potential toxicities. Results will be used to support an Investigational New Drug Application with the FDA for a clinical trial addressing patients with COVID-19 infection.